Consultant Clinical Oncologist
University Hospitals Bristol, United Kingdom
Amit Bahl is Consultant Clinical Oncologist with a special interest in urological cancers at Bristol Cancer Institute, University Hospitals Bristol, Bristol, UK.
Prof. Bahl became Member of the Royal College of Physicians (RCP) and trained in Clinical Oncology, achieving Fellowships of the RCP and of the Royal College of Radiologists (RCR). He has also been an expert adviser to the National Institute for Health and Care Excellence (NICE) for technology appraisals on new drugs and an external service reviewer at oncology departments across the UK.
Prof. Bahl is actively involved in research into prostate, renal, bladder, and penile cancers and robotics in brachytherapy. He is the Clinical Co-lead for National Kidney Cancer Audit and Chairperson of British Uro-oncology Group.
SS-02: PSMA-Targeted Radioligand Therapy
Thursday, October 30, 2025
13:05 - 13:25 GMT+0
Thursday, October 30, 2025
13:20 - 13:50 GMT+0